Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Significance of Defensin Alpha 4 in the Pathophysiology of the Adrenal Insufficiency in Inflammatory Lung Diseases

NCT01703013 is registered in ClinicalTrials.gov with Cantonal Hospital of St. Gallen as lead sponsor.

NCT NCT01703013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01703013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Significance of Defensin Alpha 4 in the Pathophysiology of the Adrenal Insufficiency in Inflammatory Lung Diseases
Lead sponsor
Cantonal Hospital of St. Gallen
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2013
Completion date
Not reported
Enrollment
75 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal insufficiency, inflammatory lung diseases